STP-902

N/A

Report date: 2022/02/15 16:47:25
NME

Base Information

Drug NameSTP-902
Drug Alias NameSTP-902
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionRNA interferenceC-Raf kinase inhibitors
TargetsC-Raf kinase
Therapy Area/IndicationsHead and Neck NeoplasmsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSirnaomics Biopharmaceuticals (Suzhou) Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesSirnaomicsSirnaomics Biopharmaceuticals (Suzhou) Co Ltd
Inactive CompaniesN/A
Active IndicationsHead and Neck NeoplasmsBreast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A